FDA Approves Takeda’s Hyqvia for Maintenance of Chronic Inflammatory Demyelinating Polyneuropathy
Hyqvia is the only subcutaneous immune globulin infusion that can be administered once per month.
Hyqvia is the only subcutaneous immune globulin infusion that can be administered once per month.